A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease (clinicaltrials.gov) - Oct 22, 2026 - P2 | N=97 | Active, not recruiting | Sponsor: Novartis Pharmaceuticals | Recruiting ➔ Active, not recruiting | N=407 ➔ 97
Enrollment change • Enrollment closed • Alzheimer's Disease • CNS Disorders
|